Press Releases

Date Title and Summary
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2019 Financial Results
SUNNYVALE, Calif. , Aug. 15, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2019 . Q4 Fiscal 2019 and Recent Operating Highlights Revenue increased 3 percent to $117.4 million , the highest ever
Toggle Summary New Data Demonstrating Benefits of Accuray Software Solutions Presented at the Annual Meeting of the American Association of Physicists in Medicine
SUNNYVALE, Calif. , July 24, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that studies validating the benefits of CyberKnife ®  and Radixact ®  System software innovations were shared by prominent physicists at the recent 61 st annual meeting of the American Association
Toggle Summary Accuray Provides Update on China Joint Venture Operational Progress
SUNNYVALE, Calif. , July 23, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today provided an update on the operational progress of its China joint venture, CNNC Accuray (Tianjin) Medical Technology Co., Ltd (CNNC Accuray). CNNC Accuray has received the Radiation Safety License from the
Toggle Summary Accuray To Report Fiscal 2019 Fourth Quarter and Full Year Financial Results on August 15, 2019
SUNNYVALE, Calif. , July 19, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2019 ended June 30, 2019 on Thursday, August 15, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m.
Toggle Summary Swiss Medical Network Advances Cancer Care in Switzerland with Multi-System Agreement for Accuray Radiation Therapy Systems and RaySearch Oncology Software Systems
First Multi-System Agreement by a Hospital for Both Accuray and RaySearch Products The Swiss Medical Network, Accuray and RaySearch Have Also Partnered to Expand Opportunities for Training Healthcare Professionals on the Latest Technologies SUNNYVALE, Calif.
Toggle Summary Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System
Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments SUNNYVALE, Calif. , May 1, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with Hong
Toggle Summary Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System
Only Radiotherapy System with Helical Delivery Capability and Intrafraction Motion Synchronization Functionality, Offering Expanded Versatility and Increased Precision in the Treatment of Simple to Complex Tumors SUNNYVALE, Calif. , April 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY)
Toggle Summary Accuray Reports Fiscal 2019 Third Quarter Results
SUNNYVALE, Calif. , April 23, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2019 ended March 31, 2019 . Fiscal Third Quarter Highlights Gross orders increased 12 percent year over year to $83.6 million Ending backlog
Toggle Summary Accuray to Report Fiscal 2019 Third Quarter Financial Results on April 23, 2019
SUNNYVALE, Calif. , April 2, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2019 on Tuesday, April 23, 2019 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer
Data Presented at the 2019 Genitourinary Cancers Symposium Reinforces Benefits of Short Course of Treatment Using Stereotactic Body Radiation Therapy for Low- or Intermediate-Risk Prostate Cancer SUNNYVALE, Calif. , Feb. 22, 2019 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today